Biblio

Export 1991 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2016
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
A. E. Villarreal, Grajales, S., O'Bryant, S. E., Edwards, M., López, L., Montalván, A., and Britton, G. B., Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama., J Alzheimers Dis, vol. 54, no. 3, pp. 897-901, 2016.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C., Characterization of Amyloid-β Deposits in Bovine Brains., J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.
M. Kleinschmidt, Schoenfeld, R., Göttlich, C., Bittner, D., Metzner, J. Erich, Leplow, B., and Demuth, H. - U., Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology., J Alzheimers Dis, vol. 50, no. 1, pp. 111-26, 2016.
A. Moreira, Diógenes, M. José, de Mendonça, A., Lunet, N., and Barros, H., Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline., J Alzheimers Dis, vol. 53, no. 1, pp. 85-93, 2016.
F. Clarelli, Mascia, E., Santangelo, R., Mazzeo, S., Giacalone, G., Galimberti, D., Fusco, F., Zuffi, M., Fenoglio, C., Franceschi, M., Scarpini, E., Forloni, G., Magnani, G., Comi, G., Albani, D., and Boneschi, F. Martinelli, CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients., J Alzheimers Dis, vol. 52, no. 4, pp. 1203-8, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
H. Woong Roh, Hong, C. Hyung, Lee, Y., Lee, K. Soo, Chang, K. Jung, Kang, D. Ryong, Lee, J. - D., Choi, S. Hye, Kim, S. Yoon, Na, D. L., Seo, S. Won, Kim, D. Kwan, Back, J. Hwan, Chung, Y. Ki, Lim, K. Young, Noh, J. Sung, and Son, S. Joon, Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea)., J Alzheimers Dis, vol. 53, no. 2, pp. 463-73, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers., J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers., J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers., J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers., J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers., J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests., J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit., J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
J. Middelstädt, Folkerts, A. - K., Blawath, S., and Kalbe, E., Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression., J Alzheimers Dis, vol. 54, no. 1, pp. 253-68, 2016.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
B. Brüggenjürgen, Andersohn, F., Burkowitz, J., Ezzat, N., Gaudig, M., and Willich, S. N., Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data., J Alzheimers Dis, vol. 54, no. 4, pp. 1365-1372, 2016.

Pages